John Rogers - Ariel Investments,
Holding/activity history for Bristol-Myers Squibb (BMY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 721,731 | 0.49 | Reduce 1.49% | <0.01 | $60.65 | $43,772,985 | SEC |
| 2025 Q4 | 732,677 | 0.43 | Buy | 0.43 | $53.94 | $39,520,597 | SEC |
| 2024 Q4 | 0 | 0.00 | Sell 100.00% | 0.18 | SEC | ||
| 2024 Q3 | 342,514 | 0.18 | Reduce 44.69% | 0.13 | $51.74 | $17,721,674 | SEC |
| 2024 Q2 | 619,211 | 0.28 | Reduce 2.35% | <0.01 | $41.53 | $25,715,833 | SEC |
| 2024 Q1 | 634,113 | 0.34 | Reduce 35.28% | 0.18 | $54.23 | $34,387,948 | SEC |
| 2023 Q4 | 979,748 | 0.51 | Add 50.05% | 0.17 | $51.31 | $50,270,870 | SEC |
| 2023 Q3 | 652,959 | 0.41 | Reduce 14.22% | 0.07 | $58.04 | $37,897,740 | SEC |
| 2023 Q2 | 761,208 | 0.47 | Reduce 3.21% | 0.02 | $63.95 | $48,679,252 | SEC |
| 2023 Q1 | 786,463 | 0.53 | Reduce 0.41% | <0.01 | $69.31 | $54,509,751 | SEC |
| 2022 Q4 | 789,666 | 0.58 | Reduce 1.23% | <0.01 | $71.95 | $56,816,469 | SEC |
| 2022 Q3 | 799,534 | 0.62 | Reduce 1.75% | 0.01 | $71.09 | $56,839,000 | SEC |
| 2022 Q2 | 813,761 | 0.63 | Add 2.24% | 0.01 | $77.00 | $62,660,000 | SEC |
| 2022 Q1 | 795,902 | 0.52 | Add 0.66% | <0.01 | $73.03 | $58,125,000 | SEC |
| 2021 Q4 | 790,705 | 0.42 | Reduce 7.35% | 0.03 | $62.35 | $49,300,000 | SEC |
| 2021 Q3 | 853,389 | 0.46 | Add 48.68% | 0.15 | $59.17 | $50,495,000 | SEC |
| 2021 Q2 | 573,979 | 0.36 | Reduce 18.08% | 0.08 | $66.82 | $38,353,000 | SEC |
| 2021 Q1 | 700,634 | 0.44 | Add 174.98% | 0.28 | $63.13 | $44,231,000 | SEC |
| 2020 Q4 | 254,798 | 0.18 | Reduce 21.35% | 0.06 | $62.03 | $15,805,000 | SEC |
| 2020 Q3 | 323,956 | 0.28 | Reduce 9.10% | 0.03 | $60.29 | $19,531,000 | SEC |
| 2020 Q2 | 356,396 | 0.32 | Add 164.97% | 0.20 | $58.80 | $20,956,000 | SEC |
| 2020 Q1 | 134,506 | 0.13 | Buy | 0.13 | $55.74 | $7,497,000 | SEC |